Evidence map›Paper›PMID 27455315›Full record

ArticleNutrients2016

Hypocholesterolaemic Activity of Lupin Peptides: Investigation on the Crosstalk between Human Enterocytes and Hepatocytes Using a Co-Culture System Including Caco-2 and HepG2 Cells.

Carmen Lammi, Chiara Zanoni, Simonetta Ferruzza, Giulia Ranaldi, Yula Sambuy, Anna Arnoldi

Open access · goldAbstract readComparative Study
In one paragraph

Article in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Frontiers in immunology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Bioactive Peptides from Lupin (Journal of agricultural and food chemistry · 2022
    Article
  9. Article
  10. Review
  11. Hempseed (Nutrients · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carmen LammiDepartment of Pharmaceutical Sciences, University of Milan, Milan I-20133, Italy. carmen.lammi@unimi.it.
Chiara ZanoniDepartment of Pharmaceutical Sciences, University of Milan, Milan I-20133, Italy. chiara.zanoni@guest.unimi.it.
Simonetta FerruzzaCREA, Food and Nutrition Research Centre, Rome I-00100, Italy. simonetta.ferruzza@crea.gov.it.
Giulia RanaldiCREA, Food and Nutrition Research Centre, Rome I-00100, Italy. giulia.ranaldi@crea.gov.it.
Yula SambuyCREA, Food and Nutrition Research Centre, Rome I-00100, Italy. yula.sambuy@crea.gov.it.
Anna ArnoldiDepartment of Pharmaceutical Sciences, University of Milan, Milan I-20133, Italy. anna.arnoldi@unimi.it.
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Literature indicates that peptic and tryptic peptides derived from the enzymatic hydrolysis of lupin protein are able to modulate cholesterol metabolism in human hepatic HepG2 cells and that part of these peptides are absorbed in a small intestine model based on differentiated human Caco-2 cells. In this paper, a co-culture system, including Caco-2 and HepG2 cells, was investigated with two objectives: (a) to verify whether cholesterol metabolism in HepG2 cells was modified by the peptides absorption through Caco-2 cells; (b) to investigate how lupin peptides influence cholesterol metabolism in Caco-2 cells. The experiments showed that the absorbed peptides, not only maintained their bioactivity on HepG2 cells, but that this activity was improved by the crosstalk of the two cells systems in co-culture. In addition, lupin peptides showed a positive influence on cholesterol metabolism in Caco-2 cells, decreasing the proprotein convertase subtilisin/kexin type 9 (PCSK9) secretion.

Indexed as

AnimalsAnticholesteremic AgentsCaco-2 CellsCell CommunicationCholesterolCoculture TechniquesDietary SupplementsEnterocytesHepatocytesHep G2 CellsHumansIntestinal AbsorptionLupinusPepsin APeptide FragmentsPlant ProteinsAnticholesteremic AgentsCholesterolPCSK9 protein, humanPepsin APeptide FragmentsPlant ProteinsProprotein Convertase 9Protein HydrolysatesTrypsinbioactive food peptidescholesterol metabolismintestinal absorptionLDL receptorLupinusPCSK9

Identifiers

PMID27455315
PMCPMC4963913
OpenAlexW2501848002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.